Literature DB >> 26304120

Loss of a Functionally and Structurally Distinct ld-Transpeptidase, LdtMt5, Compromises Cell Wall Integrity in Mycobacterium tuberculosis.

Leighanne A Brammer Basta1, Anita Ghosh2, Ying Pan2, Jean Jakoncic3, Evan P Lloyd4, Craig A Townsend4, Gyanu Lamichhane5, Mario A Bianchet6.   

Abstract

The final step of peptidoglycan (PG) biosynthesis in bacteria involves cross-linking of peptide side chains. This step in Mycobacterium tuberculosis is catalyzed by ld- and dd-transpeptidases that generate 3→3 and 4→3 transpeptide linkages, respectively. M. tuberculosis PG is predominantly 3→3 cross-linked, and LdtMt2 is the dominant ld-transpeptidase. There are four additional sequence paralogs of LdtMt2 encoded by the genome of this pathogen, and the reason for this apparent redundancy is unknown. Here, we studied one of the paralogs, LdtMt5, and found it to be structurally and functionally distinct. The structures of apo-LdtMt5 and its meropenem adduct presented here demonstrate that, despite overall architectural similarity to LdtMt2, the LdtMt5 active site has marked differences. The presence of a structurally divergent catalytic site and a proline-rich C-terminal subdomain suggest that this protein may have a distinct role in PG metabolism, perhaps involving other cell wall-anchored proteins. Furthermore, M. tuberculosis lacking a functional copy of LdtMt5 displayed aberrant growth and was more susceptible to killing by crystal violet, osmotic shock, and select carbapenem antibiotics. Therefore, we conclude that LdtMt5 is not a functionally redundant ld-transpeptidase, but rather it serves a unique and important role in maintaining the integrity of the M. tuberculosis cell wall.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mycobacterium tuberculosis; antibiotics; biosynthesis; cell wall; enzyme kinetics; enzyme structure; peptidoglycan

Mesh:

Substances:

Year:  2015        PMID: 26304120      PMCID: PMC4646210          DOI: 10.1074/jbc.M115.660753

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Identification of the L,D-transpeptidases responsible for attachment of the Braun lipoprotein to Escherichia coli peptidoglycan.

Authors:  Sophie Magnet; Samuel Bellais; Lionel Dubost; Martine Fourgeaud; Jean-Luc Mainardi; Sébastien Petit-Frère; Arul Marie; Dominique Mengin-Lecreulx; Michel Arthur; Laurent Gutmann
Journal:  J Bacteriol       Date:  2007-03-16       Impact factor: 3.490

2.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

3.  Crystal structure of a novel beta-lactam-insensitive peptidoglycan transpeptidase.

Authors:  Sabrina Biarrotte-Sorin; Jean-Emmanuel Hugonnet; Vanessa Delfosse; Jean-Luc Mainardi; Laurent Gutmann; Michel Arthur; Claudine Mayer
Journal:  J Mol Biol       Date:  2006-03-23       Impact factor: 5.469

4.  B. subtilis ykuD protein at 2.0 A resolution: insights into the structure and function of a novel, ubiquitous family of bacterial enzymes.

Authors:  Jakub Bielnicki; Yancho Devedjiev; Urszula Derewenda; Zbigniew Dauter; Andrzej Joachimiak; Zygmunt S Derewenda
Journal:  Proteins       Date:  2006-01-01

5.  Specificity of L,D-transpeptidases from gram-positive bacteria producing different peptidoglycan chemotypes.

Authors:  Sophie Magnet; Ana Arbeloa; Jean-Luc Mainardi; Jean-Emmanuel Hugonnet; Martine Fourgeaud; Lionel Dubost; Arul Marie; Vanessa Delfosse; Claudine Mayer; Louis B Rice; Michel Arthur
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

6.  Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics.

Authors:  Anthony R Flores; Linda M Parsons; Martin S Pavelka
Journal:  Microbiology       Date:  2005-02       Impact factor: 2.777

7.  Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams.

Authors:  Maia K Schoonmaker; William R Bishai; Gyanu Lamichhane
Journal:  J Bacteriol       Date:  2014-01-24       Impact factor: 3.490

8.  Three-dimensional structure of the bacterial cell wall peptidoglycan.

Authors:  Samy O Meroueh; Krisztina Z Bencze; Dusan Hesek; Mijoon Lee; Jed F Fisher; Timothy L Stemmler; Shahriar Mobashery
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-09       Impact factor: 11.205

9.  Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate.

Authors:  Jean-Emmanuel Hugonnet; John S Blanchard
Journal:  Biochemistry       Date:  2007-10-04       Impact factor: 3.162

10.  The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation.

Authors:  Marie Lavollay; Michel Arthur; Martine Fourgeaud; Lionel Dubost; Arul Marie; Nicolas Veziris; Didier Blanot; Laurent Gutmann; Jean-Luc Mainardi
Journal:  J Bacteriol       Date:  2008-04-11       Impact factor: 3.490

View more
  18 in total

1.  Two dd-Carboxypeptidases from Mycobacterium smegmatis Affect Cell Surface Properties through Regulation of Peptidoglycan Cross-Linking and Glycopeptidolipids.

Authors:  Satya Deo Pandey; Shilpa Pal; Ganesh Kumar N; Ankita Bansal; Sathi Mallick; Anindya S Ghosh
Journal:  J Bacteriol       Date:  2018-06-25       Impact factor: 3.490

2.  Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations.

Authors:  Victor T Sabe; Gideon F Tolufashe; Collins U Ibeji; Sibusiso B Maseko; Thavendran Govender; Glenn E M Maguire; Gyanu Lamichhane; Bahareh Honarparvar; Hendrik G Kruger
Journal:  J Mol Model       Date:  2019-10-28       Impact factor: 1.810

3.  Phylogenetic and Biochemical Analyses of Mycobacterial l,d-Transpeptidases Reveal a Distinct Enzyme Class That Is Preferentially Acylated by Meropenem.

Authors:  Trevor A Zandi; Robert L Marshburn; Paige K Stateler; Leighanne A Brammer Basta
Journal:  ACS Infect Dis       Date:  2019-10-14       Impact factor: 5.084

4.  Investigating β-Lactam Drug Targets in Mycobacterium tuberculosis Using Chemical Probes.

Authors:  Samantha R Levine; Kimberly E Beatty
Journal:  ACS Infect Dis       Date:  2021-01-20       Impact factor: 5.084

5.  Allosteric cooperation in β-lactam binding to a non-classical transpeptidase.

Authors:  Nazia Ahmad; Sanmati Dugad; Varsha Chauhan; Shubbir Ahmed; Kunal Sharma; Sangita Kachhap; Rana Zaidi; William R Bishai; Gyanu Lamichhane; Pankaj Kumar
Journal:  Elife       Date:  2022-04-27       Impact factor: 8.713

6.  Evaluation of Carbapenems for Treatment of Multi- and Extensively Drug-Resistant Mycobacterium tuberculosis.

Authors:  Sander P van Rijn; Marlanka A Zuur; Richard Anthony; Bob Wilffert; Richard van Altena; Onno W Akkerman; Wiel C M de Lange; Tjip S van der Werf; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 7.  β-Lactam Resistance Mechanisms: Gram-Positive Bacteria and Mycobacterium tuberculosis.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

8.  Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.

Authors:  Pankaj Kumar; Varsha Chauhan; José Rogério A Silva; Jerônimo Lameira; Felipe B d'Andrea; Shao-Gang Li; Stephan L Ginell; Joel S Freundlich; Cláudio Nahum Alves; Scott Bailey; Keira A Cohen; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 9.  Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors:  Elizabeth Story-Roller; Gyanu Lamichhane
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

10.  Competing off-loading mechanisms of meropenem from an l,d-transpeptidase reduce antibiotic effectiveness.

Authors:  Trevor A Zandi; Craig A Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.